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Background: The non-invasive identification of vulnerable plaque would be a major advance. These plaques have certain pathological 
characteristics, particularly micro-calcification and inflammation. Using PET/CT we investigated coronary uptake of 18F-NaF and 18F-FDG as markers 
of active plaque calcification and inflammation respectively.
Methods: We prospectively recruited 119 volunteers (age 72±8, 68% male) and measured their coronary calcium score and 18F-NaF and 18F-FDG 
uptake. Patients with a calcium score of 0 were used as controls and compared to those with calcific atherosclerosis (ca score >0).
Results: Repeatability statistics for the measurement of the coronary 18F-NaF uptake (max TBR) were excellent (intra-class coefficient 0.99). 
Activity was higher in patients with coronary atherosclerosis versus controls (1.64±0.49 vs 1.23±0.24; p<0.01) and correlated with the calcium 
score (r=0.65, p<0.01) although 40% of those with scores >1000 displayed normal uptake. Patients with increased coronary 18F-NaF (n=40) had 
higher rates of prior cardiovascular events (P=0.02) and angina (p=0.02) and higher Framingham risk scores (P=0.01). By contrast quantification of 
coronary 18F-FDG activity was hampered by myocardial uptake and not increased in those with atherosclerosis versus controls (p=0.50).
Conclusion: 18F-NaF is a promising new approach for the assessment of coronary plaque biology and appears to be a novel marker of 
vulnerability, recent plaque rupture and cardiovascular risk
